InvestorLens

RPRX — ROYALTY PHARMA PLC

Public company

Sign in to save3 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About ROYALTY PHARMA PLC (RPRX)

ROYALTY PHARMA PLC (RPRX) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $207M. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in RPRX

100
/100
Strong Institutional Accumulation
Added / Increased1
Reduced0
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track RPRX

20
/100
Emerging Interest
3investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

RPRX Ownership Composition

How ROYALTY PHARMA PLC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Other
86% of tracked value
Institutions
3
tracked investors
Total Reported
$169M
combined 13F value
Sectors2
  • Other86.1%
  • Hedge Funds13.9%
Other(2)
86.1%
Hedge Funds(1)
13.9%

Tracked investors reporting RPRX

  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    2.9M
    Value
    $141M
    % Portfolio
    0.02%
  • Steve CohenMar 31, 2026
    Point72 Asset Management
    Shares
    490K
    Value
    $23.5M
    % Portfolio
    0.03%
  • Izzy EnglanderDec 31, 2025
    Millennium Management
    Shares
    116.8K
    Value
    $4.5M
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold RPRX?
3 tracked institutional investors disclosed a position in RPRX (ROYALTY PHARMA PLC) in their most recent 13F filing.
Who is the largest institutional holder of RPRX?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in RPRX, valued at $207M.
Did institutional ownership of RPRX increase or decrease?
Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited RPRX.
Where does this RPRX ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
RPRX (ROYALTY PHARMA PLC) — Institutional Holders & 13F — InvestorLens